Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Adjali
Iqbal Adjali, Sharnbrook GB
| Patent application number | Description | Published |
|---|---|---|
| 20090006242 | Automated auctioning method for market evaluation - In an automatic auctioning method for determining market valuations, the auction process operates in two rounds, whereby the first round is a “sealed bid first price” auction while the second round is an “ascending price” auction. All bids and the winners of both rounds are kept confidential until the second round is completed. Data on bids made and consequential winning results are analysed and processed. | 01-01-2009 |
Iqbal Adjali, Sharebrook GB
| Patent application number | Description | Published |
|---|---|---|
| 20080306808 | Purchases method and system - In an automated method for providing personalised recommendations to a user, a global probabilistic purchase model based on prior interactions of a group of users of a system, is used in the generation of personalised recommendations for future purchases for a given user. Attributes of the given user are used to identify characteristics relating to the user's personal purchasing, correction factors are calculated to update the output of the global probabilistic purchase model to personalise the recommendations for the user. | 12-11-2008 |
Oumeya Adjali, Montpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20080206210 | Drugs for the Prevention or Treatment of Immunodeficiencies, Autoimmune Diseases or for the Induction of Immune Tolerance - The invention relates to the use of viral vectors able to stably integrate into the genome of thymic stromal cells, or of intrathymic lymphocytes or lymphocytes precursors, for the manufacture of a medicine intended for intrathymic administration in the frame of the prevention or treatment of genetic immunodeficiencies, acquired immunodeficiencies, or for the induction of immune tolerance of the organism to self or non-self gene products, cells or tissues, or for the prevention or treatment of autoimmune diseases. | 08-28-2008 |
